Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed No phase listed Observational

Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)

ClinicalTrials.gov ID: NCT05845593

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05845593. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 8:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Multicenter Study to Assess the Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With Systemic Lupus Erythematosus (SLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label study to determine the association of the data obtained with LuGENE®, a transcriptomic-based LDT, with standard evaluation of patients diagnosed with SLE, including clinical involvement, SLEDAI score, Physician Global Assessment (PGA) and standard laboratory measures, including ANA, anti-DNA, anti-RNP and complement components C3 and C4, as well as Patient Reported Outcomes capturing pain, fatigue and Health-Related Quality of Life. The test will be administered on one occasion to patients with a clinical diagnosis of lupus or incomplete lupus and clinical and laboratory features evaluated contemporaneously. This trial includes a pilot study of approximately 10 subjects from 2-3 sites to assess whether the delivery times of LuGENE® laboratory results do not exceed more than 7 business days.

Study identification

NCT ID
NCT05845593
Recruitment status
Not listed
Study type
Observational
Phase
Not listed
Lead sponsor
Ampel BioSolutions, LLC
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2023 (Actual)
Primary completion
Dec 10, 2024 (Estimated)
Completion
Mar 5, 2025 (Estimated)
Last update posted
May 3, 2024

2023 – 2025

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research, PLLC Phoenix Arizona 85032 Not yet recruiting
Cedars-Sinai Medical Center Los Angeles California 90048 Recruiting
Providence St. John's Health Center - Rheumatology Santa Monica California 90404 Not yet recruiting
Yale School of Medicine New Haven Connecticut 06519 Not yet recruiting
Rush University Medical Center Chicago Illinois 60612 Not yet recruiting
University of Maryland School of Medicine Baltimore Maryland 21201 Not yet recruiting
Mayo Clinic Rochester Minnesota 55096 Not yet recruiting
Feinstein Institute for Medical Research Manhasset New York 11030 Recruiting
The Hospital for Special Surgery New York New York 10021 Not yet recruiting
Arthritis and Osteoporosis Consultants of the Carolinas Charlotte North Carolina 28207 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05845593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2024 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.